LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1Acura Labs
04 1Apicore LLC
05 1Arene Lifesciences
06 1Aspire Lifesciences Pvt Ltd
07 1Aurobindo Pharma Limited
08 1Aurore Life Sciences
09 1Chromo Laboratories
10 1Divis Laboratories
11 1Emcure Pharmaceuticals
12 2Hetero Drugs
13 1Laurus Labs
14 1Lee Pharma
15 2Lupin Ltd
16 1Maithri Drugs
17 1Prajna Generics
18 1SGMR Pharmaceuticals
19 1SMS Pharmaceuticals
20 1Saintsun Pharma
21 1Shanghai Desano Chemical Pharmaceutical Co., Ltd.
22 1Shenzhen Oriental Pharmaceutical
23 1Teva Pharmaceutical Industries
24 1Tianish Laboratories
25 2Viatris
26 1Viwit Pharmaceuticals Limited
Reset all filters
01 4China
02 21India
03 1Israel
04 3U.S.A
Reset all filters
01 7Active
02 2Inactive
03 20Blank
01 2Valid
02 27Blank
Reset all filters
01 29Blank
Reset all filters
01 1WC-0030
02 1WC-0040
03 1WC-0213
04 1WC-0436
05 1WC0436
06 24Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2013-12-09
DMF Number : 27728
Submission : 2013-12-24
Status : Active
Type : II
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-02
Pay. Date : 2016-06-21
DMF Number : 30595
Submission : 2016-06-24
Status : Active
Type : II
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-08-25
DMF Number : 34206
Submission : 2019-09-30
Status : Active
Type : II
Date of Issue : 2019-01-28
Valid Till : 2022-01-27
Written Confirmation Number : WC-0436
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25261
Submission : 2011-09-06
Status : Active
Type : II
Date of Issue : 2022-07-04
Valid Till : 2025-07-03
Written Confirmation Number : WC-0040
Address of the Firm :
NDC Package Code : 65977-0049
Start Marketing Date : 2001-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-08
Pay. Date : 2023-01-10
DMF Number : 37182
Submission : 2022-12-10
Status : Active
Type : II
NDC Package Code : 65977-0049
Start Marketing Date : 2001-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36083
Submission : 2021-06-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25753
Submission : 2012-04-02
Status : Inactive
Type : II
Date of Issue : 2019-01-28
Valid Till : 2022-01-27
Written Confirmation Number : WC0436
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26935
Submission : 2013-03-28
Status : Inactive
Type : II
53
PharmaCompass offers a list of Raltegravir Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Raltegravir Potassium manufacturer or Raltegravir Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Raltegravir Potassium manufacturer or Raltegravir Potassium supplier.
PharmaCompass also assists you with knowing the Raltegravir Potassium API Price utilized in the formulation of products. Raltegravir Potassium API Price is not always fixed or binding as the Raltegravir Potassium Price is obtained through a variety of data sources. The Raltegravir Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Raltegravir Potassium Salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raltegravir Potassium Salt, including repackagers and relabelers. The FDA regulates Raltegravir Potassium Salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raltegravir Potassium Salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Raltegravir Potassium Salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Raltegravir Potassium Salt supplier is an individual or a company that provides Raltegravir Potassium Salt active pharmaceutical ingredient (API) or Raltegravir Potassium Salt finished formulations upon request. The Raltegravir Potassium Salt suppliers may include Raltegravir Potassium Salt API manufacturers, exporters, distributors and traders.
click here to find a list of Raltegravir Potassium Salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 26 companies offering Raltegravir Potassium Salt
Get in contact with the supplier of your choice: